Qiao Y, Fayyaz A, Ding Y, Ji X, Zhao W
Brain Circ. 2025; 10(4):283-295.
PMID: 40012589
PMC: 11850935.
DOI: 10.4103/bc.bc_159_24.
Dean Y, Mohamed M, Shokri A, Nassar M, Omayer A, Shahid M
Obes Surg. 2025; .
PMID: 40000567
DOI: 10.1007/s11695-025-07750-7.
Al-Hazmi A, Alanazi A, Thirunavukkarasu A, Alriwely N, Alrais M, Alruwaili A
Front Public Health. 2025; 12:1378561.
PMID: 39872100
PMC: 11770004.
DOI: 10.3389/fpubh.2024.1378561.
Virrueta N, Valdiviez V, Beutel T, Titus O, Peauroi S, Billups S
J Manag Care Spec Pharm. 2025; 31(1):33-41.
PMID: 39745844
PMC: 11695840.
DOI: 10.18553/jmcp.2025.31.1.33.
Matsumura K, Nakagomi A, Yagi E, Yamada N, Funauchi Y, Kakehi K
JMIR Cardio. 2024; 8:e52266.
PMID: 39621938
PMC: 11612529.
DOI: 10.2196/52266.
The Problems and Needs of Self-Management Among Indonesian Older Adults With Hypertension: A Qualitative Study.
Khasanah U, Kelliat B, Afiyanti Y, Besral B, Sari D
SAGE Open Nurs. 2024; 10:23779608241282915.
PMID: 39411708
PMC: 11475112.
DOI: 10.1177/23779608241282915.
Therapeutic Drug Monitoring and the Challenge of Conducting Trials to Improve Antihypertensive Medication Adherence.
Muntner P, Tanner R
Am J Hypertens. 2024; 37(10):745-747.
PMID: 38832430
PMC: 11403019.
DOI: 10.1093/ajh/hpae075.
Adherence to Antihypertensive Therapy and Its Determinants: A Systematic Review.
Ferreira Jr P, Simoes Sr J, Velho Sr D
Cureus. 2024; 16(5):e59532.
PMID: 38826951
PMC: 11144025.
DOI: 10.7759/cureus.59532.
Hypertension Medication and Medicare Beneficiaries: Prescription Drug Coverage Satisfaction and Medication Non-Adherence among Older Adults.
Park J, Kim K, Medina M, Ng B, Smith M, Edafetanure-Ibeh O
Healthcare (Basel). 2024; 12(7).
PMID: 38610145
PMC: 11011680.
DOI: 10.3390/healthcare12070722.
Defining Meaningful Change in Antihypertensive Medication Adherence in Adults with Established Hypertension: Implications for Clinical Practice.
Peacock E, Muntner P, Craig L, Silver J, Mills K, Chen J
Med Clin North Am. 2024; 107(6S):e39-e52.
PMID: 38609280
PMC: 11233029.
DOI: 10.1016/j.mcna.2023.06.008.
Trends in the Prevalence of Multiple Chronic Conditions Among US Adults With Hypertension From 1999-2000 Through 2017-2020.
Alanaeme C, Ghazi L, Akinyelure O, Wen Y, Christenson A, Poudel B
Am J Hypertens. 2024; 37(7):493-502.
PMID: 38576398
PMC: 11519032.
DOI: 10.1093/ajh/hpae040.
The Impact of Non-pharmacological Interventions on Blood Pressure Control in Patients With Hypertension: A Systematic Review.
Ballut O, Alzahrani A, Alzahrani R, Alzahrani A, Alzahrani R, Alzahrani M
Cureus. 2023; 15(11):e48444.
PMID: 38074046
PMC: 10702403.
DOI: 10.7759/cureus.48444.
Antihypertensive drug concentration measurement combined with personalized feedback in resistant hypertension: a randomized controlled trial.
Peeters L, Kappers M, Hesselink D, van der Net J, Hartong S, van de Laar R
J Hypertens. 2023; 42(1):169-178.
PMID: 37796233
PMC: 10713002.
DOI: 10.1097/HJH.0000000000003585.
When blood pressure refuses to budge: exploring the complexity of resistant hypertension.
Champaneria M, Patel R, Oroszi T
Front Cardiovasc Med. 2023; 10:1211199.
PMID: 37416924
PMC: 10322223.
DOI: 10.3389/fcvm.2023.1211199.
Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke.
Zhong J, Gao Y, Huang D, Hu Y, He Q, Diao L
Brain Behav. 2023; 13(5):e2982.
PMID: 37062920
PMC: 10175999.
DOI: 10.1002/brb3.2982.
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems.
Baryakova T, Pogostin B, Langer R, McHugh K
Nat Rev Drug Discov. 2023; 22(5):387-409.
PMID: 36973491
PMC: 10041531.
DOI: 10.1038/s41573-023-00670-0.
Secondary Ischemic Stroke Prevention.
Bangad A, Abbasi M, de Havenon A
Neurotherapeutics. 2023; 20(3):721-731.
PMID: 36877331
PMC: 10275832.
DOI: 10.1007/s13311-023-01352-w.
Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study.
Yang R, Tang J, Kuang M, Liu H
Ann Med. 2023; 55(1):276-284.
PMID: 36594446
DOI: 10.1080/07853890.2022.2162113.
Laboratory testing and antihypertensive medication adherence following initial treatment of incident, uncomplicated hypertension: A real-world data analysis.
Beall R, Leung A, Quinn A, Salmon C, Scory T, Bresee L
J Clin Hypertens (Greenwich). 2022; 24(10):1316-1326.
PMID: 36125169
PMC: 9581099.
DOI: 10.1111/jch.14567.
Low educational status correlates with a high incidence of mortality among hypertensive subjects from Northeast Rural China.
Yu S, Guo X, Li G, Yang H, Zheng L, Sun Y
Front Public Health. 2022; 10:951930.
PMID: 36091501
PMC: 9453591.
DOI: 10.3389/fpubh.2022.951930.